Gaurav Varma

6PUBLICATIONS
48CO-AUTHORS
Haematological tumoursGene and molecular therapyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 05, 2025
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.

Gaurav Varma, Lindsay Fogel, Beth Gordon

|Apr 03, 2024
KLRG1, Another Opportunity for a Breakthrough in MTCL.

Gaurav Varma, Catherine S Diefenbach

|Aug 15, 2023
On the Precipice of a "Rituximab-Like" Era for T-Cell Lymphomas?

Gaurav Varma, Catherine S Diefenbach

|Jul 14, 2023
Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma.

Eileen M Boyle, Patrick Blaney, James H Stoeckle

|Jun 21, 2022
Polatuzumab vedotin in relapsed / refractory aggressive B-cell lymphoma.

Gaurav Varma, Jacqueline Wang, Catherine Diefenbach

|Jul 20, 2021
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.

Juan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens

Pageof 1

Frequent Collaborators

3 joint publications

Catherine S Diefenbach

1 joint publications

Juan Pablo Alderuccio

1 joint publications

Mark Bower

1 joint publications

Catherine Zhu